Lv4
480 积分 2022-11-23 加入
FDA关于致癌性试验“特别方案评估”的流程和相关法规的介绍与探讨
5天前
已关闭
RNAi-based drug design: considerations and future directions
19天前
已完结
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
22天前
已完结
Historical Control Background Incidence of Spontaneous Nonneoplastic Lesions of Sprague Dawley Rats in 104-Week Carcinogenicity Studies
1个月前
已完结
Telomerase inhibitor imetelstat kills AML cells via lipid ROS and ferroptosis
2个月前
已完结
Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1
2个月前
已关闭
In Vitro Assessment of the Hepatotoxicity Potential of Therapeutic Oligonucleotides
3个月前
已完结
In vivo immunological activity of chitosan-derived nanoparticles
3个月前
已完结
Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation
4个月前
已完结
Using RNA-seq to Assess Off-Target Effects of Antisense Oligonucleotides in Human Cell Lines
4个月前
已完结
皖公网安备34019202002308
